The Effect of Progestins on Behavioral Stress Responses in Postmenopausal Women

OBJECTIVE: We assessed the effects of progestin when added to estrogen on the adaptive patterns to provoked stress in postmenopausal women. METHODS: Fourteen postmenopausal women were randomized to receive either a transdermal estrogen patch (TE2) (n = 7) for 6 weeks or TE2 with added medroxyprogesterone acetate (10 mg) (TE2/MPA) (n = 7) for the last 10 days of the 6-week regimen. Behavioral stress tests were administered to each group, with measurements of biophysical and neuroendocrine responses. In a crossover fashion, after each group received the first treatment and testing, treatment was continued for another 6 weeks with the alternate regimen, at which time another stress test was administered. Responses to stress in the two treatment groups were compared to each other and to established placebo responses. RESULTS: Biophysical responses in the TE2 group were significantly blunted compared to both TE2/MPA and placebo responses (P < .05). Without MPA treatment, there were significantly blunted speech (P < .05) and cold pressor (P < .01) blood pressure responses. With added progestin, there was a greater systolic blood pressure response (P < .01) compared with estrogen alone. Both groups (TE2 and TE 2/MPA) had blunted and nonsignificant responses of ACTH and cortisol upon testing, whereas the placebo group showed a significant response (P < .01). Plasma norepinephrine responses, however, were significantly blunted after TE2, compared with the increased responses observed with both TE2/MPA and placebo (P < .01). CONCLUSION: Although estrogen significantly reduces behaviorally induced stress reactivity in postmenopausal women, certain doses of progestin administration may blunt this effect. (J Soc Gynecol Invest 1994;1:79-83)

[1]  R. Lobo,et al.  A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin. , 1993, Fertility and sterility.

[2]  L. Bernstein,et al.  Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen , 1993 .

[3]  R. Lobo The role of progestins in hormone replacement therapy , 1993, American journal of obstetrics and gynecology.

[4]  T. Bourne,et al.  Differential effects of transdermal estradiol and sequential progestogens on impedance to flow within the uterine arteries of postmenopausal women. , 1992, Fertility and sterility.

[5]  E. Eaker,et al.  The risk of acute myocardial infarction after oestrogen and oestrogen‐progestogen replacement , 1992, British journal of obstetrics and gynaecology.

[6]  D. Herrington,et al.  Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. , 1992, Journal of the American College of Cardiology.

[7]  M. Pike,et al.  A reevaluation of estrogen status in postmenopausal women who smoke. , 1992, American journal of obstetrics and gynecology.

[8]  R. Lobo,et al.  Clinical review 27: Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women. , 1991, The Journal of clinical endocrinology and metabolism.

[9]  R. Reid,et al.  A Randomized, Double-Blind, Placebo- Controlled, Cross-Over Trial to Assess the Side Effects of Medroxyprogesterone Acetate in Hormone Replacement Therapy , 1991, Obstetrics and gynecology.

[10]  B. Henderson,et al.  Decreased Mortality in Users of Estrogen Replacement Therapy , 1991, Archives of internal medicine.

[11]  A Steptoe,et al.  Methodology of mental stress testing in cardiovascular research. , 1991, Circulation.

[12]  G. Colditz,et al.  Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence☆☆☆ , 1991 .

[13]  C. Christiansen,et al.  Influence of menopause on serum lipids and lipoproteins. , 1990, Maturitas.

[14]  M. Laakso,et al.  Ischemic heart disease risk in postmenopausal women. Effects of estrogen use on glucose and insulin levels. , 1990, Arteriosclerosis.

[15]  H. S. Klopfenstein,et al.  Estrogen modulates responses of atherosclerotic coronary arteries. , 1990, Circulation.

[16]  B. Sherwin,et al.  A Prospective One-Year Study of Estrogen and Progestin in Postmenopausal Women: Effects on Clinical Symptoms and Lipoprotein Lipids , 1989, Obstetrics and gynecology.

[17]  K. Matthews,et al.  Premenopausal and postmenopausal women differ in their cardiovascular and neuroendocrine responses to behavioral stressors. , 1989, Psychophysiology.

[18]  E. Barrett-Connor,et al.  Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. , 1987, Circulation.

[19]  H. Rüddel,et al.  The standardized mental stress test protocol: test-retest reliability and comparison with ambulatory blood pressure monitoring. , 1985, Psychophysiology.

[20]  T. Bäckström,et al.  CYCLICAL MOOD CHANGES AS IN THE PREMENSTRUAL TENSION SYNDROME DURING SEQUENTIAL ESTROGEN‐PROGESTAGEN POSTMENOPAUSAL REPLACEMENT THERAPY , 1985, Acta obstetricia et gynecologica Scandinavica.

[21]  S. Manuck,et al.  Behaviorally Induced Heart Rate Reactivity and Atherosclerosis in Cynomolgus Monkeys , 1983, Psychosomatic medicine.

[22]  J. Henry,et al.  The role of psychosocial factors in the development of arteriosclerosis in CBA mice. Observations on the heart, kidney and aorta. , 1971, Atherosclerosis.

[23]  H. Luginbühl,et al.  Coronary arteriosclerosis in swine: evidence of a relation to behavior. , 1969, Journal of comparative and physiological psychology.